Medicine and Dentistry
Patient
58%
Antiretroviral Therapy
43%
Therapeutic Procedure
33%
Highly Active Antiretroviral Therapy
29%
Human Immunodeficiency Virus
28%
Cell Count
19%
Disease
16%
Drug
14%
Human Immunodeficiency Virus Infection
13%
Cohort Analysis
13%
Follow up
11%
Woman
10%
Cells
9%
Human Immunodeficiency Virus 1 Infection
8%
Clinical Significance
8%
Man
8%
Person
7%
Pneumonia
6%
Child
6%
CD8 Antigen
6%
Proteinase Inhibitor
6%
Immune Deficiency
5%
Complication
5%
Nonnucleoside Reverse Transcriptase Inhibitor
5%
Tuberculosis
5%
Gene
5%
Treatment Interruption
5%
Pneumocystis Pneumonia
5%
Diagnosis
5%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Cytotoxic T-Cell
27%
T-Helper Cell
27%
Epitope
24%
Viral Load
24%
Human Immunodeficiency Virus Infection
20%
T Cell Receptor
11%
Viral Disease
9%
Cytotoxic T Cell
7%
Hypersensitive Response
7%
Immune Reconstitution Inflammatory Syndrome
6%
Memory T Cell
5%
CD4 Lymphocyte Percentage
5%
Enzyme-Linked Immunospot Assay
5%
